Skip to main content

Stepwise Mammary Carcinogenesis: Immunological Considerations

  • Chapter
Early Breast Cancer

Abstract

The literature provides ample evidence that mammary carcinogenesis is a nonrandom event influenced by such risk factors as ethnic group, family history, age, parity and, perhaps, nutritional factors (Lilienfeld 1963; Macklin 1959; Vakil and Morgan 1973). It is, therefore, not surprising that patients who develop a cancer in one breast are at a greatly increased risk of developing a second primary breast cancer (Harrington 1946; McCredie et al. 1975). In response to such observations some have gone so far as to recommend prophylactic removal of the “second” breast (Leis 1979). Certainly it is clinically and conceptually important to take note of the increased risk of second breast cancers. However, it may be of even greater importance to consider the paradox that among patients who have the necessary and sufficient requirements to develop breast cancer, only a small minority will develop a primary cancer in the second breast. This is all the more surprising in view of the similarity in microscopic structure, mammographic patterns, and physical proximity of the two breasts. Moreover, the relatively low incidence of second primaries persists regardless of the age at diagnosis of the first lesion, family history, parity, or any constellation of known risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akiyoski T, Nakamura Y, Kawaguchi M, Tsuji H (1978) Cellular hypersensitivity to autologous tumor extracts in patients with breast carcinoma. Jpn J Surg 8: 236–241

    Article  Google Scholar 

  • Black MM (1965) Reactivity of the lymphoreticuloendothelial system in human cancer. Prog Clin Cancer 1: 26–49

    Google Scholar 

  • Black MM (1972) Cellular and biologic manifestations of immunogenicity in precancerous mastopathy. Natl Cancer Inst Monogr 35: 73–82

    PubMed  CAS  Google Scholar 

  • Black MM (1973) Human breast cancer. A model for cancer immunology. Isr J Med Sci 9: 284–299

    PubMed  CAS  Google Scholar 

  • Black MM (1975) Immunology of breast cancer: Clinical implications. Prog Clin Cancer 6: 115–138

    PubMed  CAS  Google Scholar 

  • Black MM (1976) Structural, antigenic and biologic characteristics of precancerous mastopathy. Cancer Res 36: 2596–2604

    PubMed  CAS  Google Scholar 

  • Black MM (1977) Immunopathology of breast cancer. Pathobiol Ann 7: 213–230

    CAS  Google Scholar 

  • Black MM, Chabon AB (1969) In situ carcinoma of the breast. Pathol Annu 4: 185–210

    Google Scholar 

  • Black MM, Kwon CS (1978) Prognostic factors. In: Gallager HS, Leis HP, Jr, Snyderman RK, Urban JA (eds) The breast. Mosby St. Louis, pp 297–319

    Google Scholar 

  • Black MM, Kwon CS (1980) Precancerous mastopathie: Structural and biological considerations. Pathol Res Pract 116: 491–514

    Google Scholar 

  • Black MM, Leis HP Jr (1970) Human breast carcinoma. III. Cellular responses to autologous breast cancer: Skin window procedure. NY State J Med 70: 2583–2589

    Google Scholar 

  • Black MM, Leis HP Jr (1971) Cellular responses to autologous breast cancer tissue: Correlation with stage and lymphoreticuloendothelial reactivity. Cancer 28: 263–273

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Leis HP Jr (1973) Cellular responses to autologous breast cancer tissue: Sequential observations. Cancer 32: 384–389

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Speer FD (1959) Immunology of cancer. Surg Gynecol Obstet 109: 105–116

    PubMed  CAS  Google Scholar 

  • Black MM, Zachrau RE (1978) Immunotherapy of breast cancer? In: Gallager HS, Leis HP Jr, nyderman RK, Urban JA (eds). The breast. Mosby St. Louis, pp 393–408

    Google Scholar 

  • Black MM, Zachrau RE (1979) Antitumor immunity in breast cancer patients: Biologic and therapeutic implications. J Reprod Med 23: 21–32

    PubMed  CAS  Google Scholar 

  • Black MM, Speer FD, Opler SR (1956) Structural representations of the tumor-host relationships in mammary carcinoma, biologic and prognostic significance. Am J Clin Pathol 26: 250–265

    PubMed  CAS  Google Scholar 

  • Black MM, Cutler SJ, Barclay THC (1972) Post biopsy breast carcinoma: A natural experiment in cancer immunology. Cancer 29: 61–65

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Leis HP Jr, Shore B, Zachrau RE (1974a) Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure. Cancer 33: 952–958

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Moore DH, Shore B, Zachrau RE, Leis HP Jr (1974b) Effect of murine milk samples and human breast tissues on human leukocyte migration indices. Cancer Res 34: 1054–1060

    PubMed  CAS  Google Scholar 

  • Black MM, Zachrau RE, Shore B, Moore DH, Leis HP Jr (1975a) Prognostically favorable immunogens of human breast cancer tissue: Antigenic similarity to murine mammary tumor virus. Cancer 35: 121–128

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Barclay THC, Hankey BF (1975b) Prognosis in breast cancer utilizing histologic characteristics, of the primary tumor. Cancer 36: 2048–2055

    Article  PubMed  CAS  Google Scholar 

  • Black MM, Zachrau RE, Shore B, Dion AS, Leis HP Jr (1978) Cellular immunity to autologous breast cancer and RHI-murine mammary tumor virus preparations. Cancer Res 38: 2068–2076

    PubMed  CAS  Google Scholar 

  • Black MM, Zachrau RE, Dion AS, Katz M (1983a) Vitamin A stimulation of specific cell-mediated immunity in breast cancer patients. Fed Proc 42: 1197

    Google Scholar 

  • Black MM, Zachrau RE, Dion AS, Katz M (1983b) Stimulation of prognostically favorable cellmediates immunity of breast cancer patients by high dose vitamin A and vitamin E. In: Prasad KN (ed) Vitamins, Nutrition and Cancer. Karger Basel, 134–146

    Google Scholar 

  • Cannon GB, Dean JH, Herberman RB, Keets M. Alford C (1981) Lymphoproliferative responses to autologous tumor extracts as prognostic indicators in patients with resected breast cancer. Int J Cancer 27: 131–138

    Article  PubMed  CAS  Google Scholar 

  • Harrington SW (1946) Survival rates of radical mastectomy for unilateral and bilateral carcinoma of the breast. Surgery 19: 154–166

    PubMed  CAS  Google Scholar 

  • Herberman RB (1983) Counterpoint: Animal tumor models and their relevance to human tumor immunology. J Biol Resp Modif 2:39–46, 217–226

    Google Scholar 

  • Hewitt HB (1982) Animal tumor models and their relevance to human tumor immunology. J Biol Resp Modif 1: 107–119

    Google Scholar 

  • Leis HP Jr (1979) Selective and reconstructive surgical procedures for carcinoma of the breast. Surg Gynecol Obstet 148: 27–32

    PubMed  Google Scholar 

  • Lilienfeld AM (1963) The epidemiology of breast cancer. Cancer Res 23: 1503–1513

    PubMed  CAS  Google Scholar 

  • Macklin MT (1959) Comparison of the number of breast-cancer deaths observed in relatives of breast-cancer patients, and the number expected on the basis of mortality rates. JNCI 22: 927–951

    PubMed  CAS  Google Scholar 

  • McCredie JA, Inch WR, Anderson M (1975) Consecutive primary carcinomas of the breast. Cancer 35: 1472–1477

    Article  PubMed  CAS  Google Scholar 

  • Vakil DV, Morgan RW (1973) Etiology of breast cancer. II. Epidemiologic aspects. Can Med Assoc J 109: 201–206

    PubMed  CAS  Google Scholar 

  • Webber BL, Heise H, Neifeld JP, Costa J (1981) Risk of subsequent contralateral breast carcinoma in a population of patients with in situ breast carcinoma. Cancer 47: 2928–2932

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Black, M.M., Zachrau, R.E. (1985). Stepwise Mammary Carcinogenesis: Immunological Considerations. In: Zander, J., Baltzer, J. (eds) Early Breast Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70192-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70192-4_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70194-8

  • Online ISBN: 978-3-642-70192-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics